Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can learning about pain and exercising ease chronic back pain without drugs?

NCT ID NCT07133607

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a program of pain education and physical exercise, delivered by physiotherapists in primary care, can improve quality of life for people with chronic spinal pain. 135 adults aged 18-70 with long-term back or neck pain will be split into three groups: one gets standard care (heat and exercise), another gets the new education-plus-exercise program, and a third gets the new program plus extra body-awareness training. The goal is to see if these drug-free approaches reduce pain and improve daily living.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pain neuroscience education and therapeutic exercise
What this could lead to
If it works, this could offer a drug-free, low-cost way to improve quality of life for people with chronic back or neck pain.
What could go wrong
This is a relatively small, early-stage trial (135 participants) comparing different non-drug approaches. The benefits may be modest and may not apply to all pain types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 135 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Users of the Public Health System of Andalusia, registered in the User Database (BDU) of the Sevilla Health District. * Ages between 18 and 70. * Chronic lumbar pain lasting more than 3 months, likely due to central sensitization (likely nociplastic pain). * The diagnosis of Central Sensitization will be made according to the most recent algorithm published by Nijs et al. in Lancet. Exclusion Criteria: * Oncological pain (pain related to cancer) * Spinal fracture or spinal surgery in the previous year. * Neurological cognitive impairment that prevents understanding of pain neuroeducation (if in doubt, the Minimental Test will be performed, requiring a minimum score of 25) * Physical conditioning deficit that prevents the execution of the Physical --Education program (minimum requirement: normal execution time of \<10 seconds for the timed "Up and Go" test). * Pregnancy * Cauda equina syndrome * Chronic fatigue syndrome * Fibromyalgia * Complex Regional Pain Syndrome * Clinical conditions that may aggravate chronic spinal pain. * Associated pathologies that prevent the performance of a physical exercise program (myopathies and neurological disorders). * Currently undergoing alternative therapies. * The presence of pain in other anatomical regions, apart from spinal pain, is not a reason for exclusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain (back / neck) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.